Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
University Of Edinburgh, Institute for Genetic and Molecular Medicine (IGMM)
Western General Hospital
Edinburgh
EH4 2XR
UK
Telephone: +44 1316518696
E-mail: derek.mills@igmm.ed.ac.uk
NUTS: UKM75
Internet address(es)
Main address: https://www.ed.ac.uk/igmm
Address of the buyer profile: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA00107
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Other: Medical Research
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NCA30904 Illumina Platform
II.1.2) Main CPV code
38434540
II.1.3) Type of contract
Supplies
II.1.4) Short description
Illumina NextSeq 2000 sequencing platform.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
344 320.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
38434540
II.2.3) Place of performance
NUTS code:
UKM75
Main site or place of performance:
Western General Hospital, WTCRF, Edinburgh.
II.2.4) Description of the procurement
The Illumina NextSeq 2000 is the updated version of the NextSeq550 that is currently in use in the laboratory. The current NextSeq is working at capacity and this platform is to allow quicker turn-over of results and to ensure integration of data of current and future projects we require a platform capable of running the same Illumina chemistry and that has been validated with a number of third-party library kits. With the inclusion of reagents and benchtop sequencer at 100 % discount along with additional discounted support plan and warranties.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The products involved are manufactured purely for the purpose of research, experiment, study or development under the condition stated in the Directive (for supplies only)
Explanation
Over the last 4 years the laboratory has provided sequencing to a range of researchers using the Illumina NextSeq550 and this platform is the next generation from Illumina and is supplied only by Illumina in conjuction with consumables from the same supplier.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
17/04/2020
V.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 0
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Illumina Cambridge Ltd
Chesterford Research Park, Little Chesterford
Saffron Walden
CB10 1XL
UK
Telephone: +44 1223824907
NUTS: UKH12
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 344 320.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
(SC Ref:620579)
VI.4) Procedures for review
VI.4.1) Review body
Court of the University of Edinburgh
Edinburgh
UK
VI.5) Date of dispatch of this notice
29/04/2020